Blood Loss — Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery
Citation(s)
Alvarez JC, Santiveri FX, Ramos I, Vela E, Puig L, Escolano F Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion. 2008 Mar;48(3):519-25. doi: 10.1111/j.1537-2995.2007.01564.x. Epub 2007 Dec 7.
Bagshaw SM Acute Kidney Injury Care Bundles. Nephron. 2015;131(4):247-51. doi: 10.1159/000437152. Epub 2015 Dec 17.
Blajchman MA, Dzik S, Vamvakas EC, Sweeney J, Snyder EL Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev. 2001 Apr;15(2):108-35. doi: 10.1053/tmrv.2001.22614. No abstract available.
Burrows L, Tartter P Effect of blood transfusions on colonic malignancy recurrent rate. Lancet. 1982 Sep 18;2(8299):662. doi: 10.1016/s0140-6736(82)92764-7. No abstract available.
Hu SS Blood loss in adult spinal surgery. Eur Spine J. 2004 Oct;13 Suppl 1(Suppl 1):S3-5. doi: 10.1007/s00586-004-0753-x. Epub 2004 Jun 10.
Janssen SJ, Braun Y, Wood KB, Cha TD, Schwab JH Allogeneic blood transfusions and postoperative infections after lumbar spine surgery. Spine J. 2015 May 1;15(5):901-9. doi: 10.1016/j.spinee.2015.02.010. Epub 2015 Feb 11.
Paul JE, Ling E, Lalonde C, Thabane L Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth. 2007 Oct;54(10):799-810. doi: 10.1007/BF03021707.
Popovsky MA Transfusion-related acute lung injury: three decades of progress but miles to go before we sleep. Transfusion. 2015 May;55(5):930-4. doi: 10.1111/trf.13064. No abstract available.
Roberson RS, Bennett-Guerrero E Impact of red blood cell transfusion on global and regional measures of oxygenation. Mt Sinai J Med. 2012 Jan-Feb;79(1):66-74. doi: 10.1002/msj.21284.
Vamvakas EC, Blajchman MA Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009 Apr 9;113(15):3406-17. doi: 10.1182/blood-2008-10-167643. Epub 2009 Feb 2.
Waters JH, Ness PM Patient blood management: a growing challenge and opportunity. Transfusion. 2011 May;51(5):902-3. doi: 10.1111/j.1537-2995.2011.03122.x. No abstract available.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.